| 1. |
Pauwels RA, L fdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med, 1999, 340: 1948-1953.
|
| 2. |
Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med, 2000, 343: 1902-1909.
|
| 3. |
James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking.AmJ Respir Crit Care Med, 2005, 171: 109-114.
|
| 4. |
Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1 : the Lung Health Study. JAMA, 1994 , 272 : 1497 -1505 .
|
| 5. |
Soriano JB, Sin DD, Zhang X, et al. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest, 2007, 131: 682-689.
|
| 6. |
Decramer M, Rutten-van M lken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease ( Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet, 2005 , 365 :1552-1560.
|
| 7. |
Anzueto A, Tashkin D, Menjoge S, et al. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther, 2005, 18: 75-81.
|
| 8. |
Tashkin DP, Celli B, Senn S, et al. A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease. N Engl J Med, 2008, 359: 1543-1554.
|
| 9. |
Celli BR, Thomas NE, Anderson JA, et al. Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 2008, 178: 332 – 338.
|
| 10. |
Wedzicha JA, Calverley PMA, Seemungal TA, et al, The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol /Fluticasone Propionate or TiotropiumBromide. Am JRespir Crit Care Med, 2008, 177: 19 – 26 .
|
| 11. |
Suissa S. Medications to modify lung function decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2008 ,178: 322-323.
|
| 12. |
Powrie DJ, Wikinson TMA, Donaldson GC, et al. Effect of tiotropium on inflammation and exacerbations in chronic obstructive pulmonary disease. Eur Respir J, 2007, 30: 472.
|
| 13. |
Hattotuwa KL, Gizycki MJ, Ansari TW, et al. The Effects of Inhaled Fluticasone on Airway Inflammation in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 2002, 165: 1592-1596.
|
| 14. |
Barnes NC, Qiu YS, Pavord ID, et al. Antiinflammatory Effects of Salmeterol/ Fluticasone Propionate in Chronic Obstructive Lung Disease. Am J Respir Crit Care Med, 2006, 173: 736-743.
|
